advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 03-05-2019, 06:52 AM #5
liquidz1 liquidz1 is offline
Junior Member
 
Join Date: Feb 2017
Posts: 17
5 yr Member
liquidz1 liquidz1 is offline
Junior Member
 
Join Date: Feb 2017
Posts: 17
5 yr Member
Default

Quote:
Originally Posted by Streetlegal View Post
"Are you going to give it a try?seems to be a harmless drug other than stomach discomfort"

I thought a bit about it, but I've heard that oral administration has proved an ineffective route. The focus of the trials is on topical administration because of this and because of safety issues. Of course, it's early very, very early days.

I also worry about potential side-effects (I actually have colitis, but have also heard of possible concerns regarding dementia, though haven't read anything to this fact).

I believe that research will be coming out in a few months regarding early trials of the topical lotion. It's a long-shot. But at least it is something.

Cheers
Paul
Topical cream was made to mainly combat the side effects from pills.The studies that i have read says that oral is effective as topical
liquidz1 is offline   Reply With QuoteReply With Quote
 

Tags
distinctly, ongoing, pirenzepine, remember, sensations


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT -5. The time now is 02:13 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.